Literature DB >> 8125488

Homozygosity for a mutation in the lipoprotein lipase gene (Gly139-->Ser) causes chylomicronaemia in a boy of Spanish descent.

S M Bijvoet1, T Bruin, S Tuzgöl, H D Bakker, M R Hayden, J J Kastelein.   

Abstract

The enzyme lipoprotein lipase (LPL) plays a crucial role in triglyceride metabolism through catalysis of triglyceride-rich chylomicrons and very low density lipoproteins. Primary LPL deficiency manifests with chylomicronaemia and is caused by mutations in the LPL gene. In this paper we report a novel molecular defect (G670-->A) in exon 4 of the LPL gene, resulting in a substitution of serine for glycine at position 139 in the mature protein. We identified homozygosity for this mutation in a boy of Spanish descent. In vitro mutagenesis provided formal proof that this missense mutation completely abolishes LPL function and therefore is the cause of LPL deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125488     DOI: 10.1007/bf00212035

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  HindIII-polymorphism in the LPL-gene detected by PCR.

Authors:  T Bruin; P W Reymer; B E Groenemeyer; P J Talmud; J J Kastelein
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

3.  Organization of the human lipoprotein lipase gene and evolution of the lipase gene family.

Authors:  T G Kirchgessner; J C Chuat; C Heinzmann; J Etienne; S Guilhot; K Svenson; D Ameis; C Pilon; L d'Auriol; A Andalibi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Structural features of lipoprotein lipase. Lipase family relationships, binding interactions, non-equivalence of lipase cofactors, vitellogenin similarities and functional subdivision of lipoprotein lipase.

Authors:  B Persson; G Bengtsson-Olivecrona; S Enerbäck; T Olivecrona; H Jörnvall
Journal:  Eur J Biochem       Date:  1989-01-15

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred is caused by a Gly154-->Ser substitution in lipoprotein lipase.

Authors:  T Bruin; S Tuzgöl; D E van Diermen; N Hoogerbrugge-van der Linden; J D Brunzell; M R Hayden; J J Kastelein
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

7.  Structural and functional roles of highly conserved serines in human lipoprotein lipase. Evidence that serine 132 is essential for enzyme catalysis.

Authors:  F Faustinella; L C Smith; C F Semenkovich; L Chan
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

8.  Structure of the human lipoprotein lipase gene.

Authors:  S S Deeb; R L Peng
Journal:  Biochemistry       Date:  1989-05-16       Impact factor: 3.162

9.  Human lipoprotein lipase complementary DNA sequence.

Authors:  K L Wion; T G Kirchgessner; A J Lusis; M C Schotz; R M Lawn
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

10.  Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21.

Authors:  R S Sparkes; S Zollman; I Klisak; T G Kirchgessner; M C Komaromy; T Mohandas; M C Schotz; A J Lusis
Journal:  Genomics       Date:  1987-10       Impact factor: 5.736

View more
  1 in total

1.  Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.

Authors:  R P Surendran; M E Visser; S Heemelaar; J Wang; J Peter; J C Defesche; J A Kuivenhoven; M Hosseini; M Péterfy; J J P Kastelein; C T Johansen; R A Hegele; E S G Stroes; G M Dallinga-Thie
Journal:  J Intern Med       Date:  2012-02-13       Impact factor: 8.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.